# The Fecal Immunoassay Occult Blood Test Combined With Calprotectin Sequential Linkage Imaging Endoscopy Screening Strategy for Monitoring Tumor Changes Associated With Long-duration Ulcerative Colitis

> **NCT07742410** · — · NOT_YET_RECRUITING · sponsor: **Qilu Hospital of Shandong University** · enrollment: 250 (estimated)

## Conditions studied

- Ulcerative Colitis (UC)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07742410
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-23
- **Primary completion:** 2029-08-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-08-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07742410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07742410, "The Fecal Immunoassay Occult Blood Test Combined With Calprotectin Sequential Linkage Imaging Endoscopy Screening Strategy for Monitoring Tumor Changes Associated With Long-duration Ulcerative Colitis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07742410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*